NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+76.0%
5Y CAGR+128.9%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+76.0%/yr
Annual compound
5Y CAGR
+128.9%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
62.9x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $106.30M | +50.9% |
| 2024 | $70.45M | +87.2% |
| 2023 | $37.63M | +92.9% |
| 2022 | $19.51M | +243.6% |
| 2021 | $5.68M | +235.8% |
| 2020 | $1.69M | - |